Header Image

Investor Relations

Investor Relations

Analyst Coverage

BioCryst Pharmaceuticals Inc. is covered by the following analysts.
Firm Analyst
Bank of America Merrill Lynch

One Bryant Park

New York, NY 10036

Tazeen Ahmad
Barclays Capital Inc.

745 Seventh Avenue

New York, NY 10019

Gena Wang PhD, CFA
H.C. Wainwright & Co.

430 Park Ave

New York, NY 10022

Andrew Fein
Jefferies and Company

520 Madison Avenue.

New York, NY 10022

Maury Raycroft
JMP Securities

190 South LaSalle Street

Suite 1610

Chicago, IL 60603

Liisa Bayko
JP Morgan Securities

383 Madison Av

New York, NY 10179

Jessica Fye
Needham & Co. LLC

445 Park Ave

4th Floor

New York, NY 10022

Serge Belanger
Piper Jaffray & Co

345 Park Ave

21st Floor

New York, NY 10154

Charles Duncan
RBC Capital Markets

3 World Financial Center

200 Vesey Street

New York, NY 10281

 

Brian Abrahams, M.D.

BioCryst Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding BioCryst Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of BioCryst Pharmaceuticals or its management. BioCryst Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.